This session dealt with government efforts to promote innovation within the Livingston constituency, highlighting existing investments and plans for future funding. The discussion touched upon both financial allocations and collaborative efforts between the UK and Scottish Governments. Key points centered around significant investments made in local biotech and life science firms, as well as strategic engagements aimed at facilitating further innovation across Scotland.
Planned research and development funding for 2025-26 nationwide.
Investment by Merck in 2022 in Livingston.
Outcome
The outcome saw a reaffirmation of the UK Government's commitment to advancing innovation through strategic funding and collaboration efforts in Scotland, specifically within the Livingston constituency.
Key Contributions
Queried UK Government steps to support innovation in Livingston.
Detailed investments in Livingston, including £88,000 to SilviBio Ltd.
All content derived from official parliamentary records